To study the efficacy of an Indigenous Herbal Combination as an externalApplication in Skin itching, scaling, hyperpigmentation, discoloration, cracks & dryness
Phase 2
- Conditions
- Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
- Registration Number
- CTRI/2023/09/057534
- Lead Sponsor
- Supreem Pharmaceuticals Private Limited Mysuru
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Subjects age group between 18- 60 years, irrespective of gender.
2.Subjects even with chronic skin lesion under medication (oral & Topical Applications).
3. Different skin symptoms such as Scaling, Discoloration, Cracks in the Skin, Dryness in the Skin, Itching, Hyperpigmentation
Exclusion Criteria
Skin Conditions with open cuts, Wound & Burns
• Excessive serous and pus discharge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reduction in itching , discoloration.Timepoint: 15 days
- Secondary Outcome Measures
Name Time Method reduction in all symptoms & signs of skin lesionsTimepoint: 30days